Emanuele Marra

1.2k total citations · 1 hit paper
36 papers, 761 citations indexed

About

Emanuele Marra is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Emanuele Marra has authored 36 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Infectious Diseases. Recurrent topics in Emanuele Marra's work include HER2/EGFR in Cancer Research (6 papers), Immunotherapy and Immune Responses (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Emanuele Marra is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Immunotherapy and Immune Responses (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Emanuele Marra collaborates with scholars based in Italy, United States and United Kingdom. Emanuele Marra's co-authors include Luigi Aurisicchio, Giuseppe Roscilli, Gennaro Ciliberto, Rita Mancini, Fabio Palombo, Laura Luberto, Mariano Maffei, Giovanni Salvatori, Luigi Fattore and Alessia Noto and has published in prestigious journals such as Cancer Research, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Emanuele Marra

35 papers receiving 747 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy

2025 25 citations Eleonora Pinto, Lisa A. Lione et al. Journal of Translational Medicine profile →

Peers

Countries citing papers authored by Emanuele Marra

Since Specialization

Citations

This map shows the geographic impact of Emanuele Marra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuele Marra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuele Marra more than expected).

Fields of papers citing papers by Emanuele Marra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuele Marra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuele Marra. The network helps show where Emanuele Marra may publish in the future.

Co-authorship network of co-authors of Emanuele Marra

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuele Marra. A scholar is included among the top collaborators of Emanuele Marra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuele Marra. Emanuele Marra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy breakdown → 2025 ·Journal of Translational Medicine ·Eleonora Pinto, Lisa A. Lione, Mirco Compagnone, (unknown), Enrica Salvatori, Maria Greco, (unknown), Emanuele Marra, Luigi Aurisicchio, Giuseppe Roscilli, Antonella Conforti	25
2	A Novel Lactobacillus brevis Fermented with a Vegetable Substrate (AL0035) Counteracts TNBS-Induced Colitis by Modulating the Gut Microbiota Composition and Intestinal Barrier 2024 ·Nutrients ·Loredana Vesci, Grazia Raffaella Tundo, Sara Soldi, Serena Galletti, (unknown), Roberta Bernardini, (unknown), Laura Luberto, Emanuele Marra, Fabrizio Giorgi, Stefano Marini	5
3	Probiotics‐Containing Mucoadhesive Gel for Targeting the Dysbiosis Associated with Periodontal Diseases 2022 ·International Journal of Dentistry ·Giuseppe Giannini, (unknown), (unknown), Sara Soldi, Marina Elli, Piera Valenti, Luigi Rosa, Emanuele Marra, (unknown), Emilio Merlo Pich	10
4	Toxicity and Local Tolerance of COVID- eVax, a Plasmid DNA Vaccine for SARS-CoV-2, Delivered by Electroporation 2021 ·Toxicologic Pathology ·Yuval Ramot, Gianfranco Caselli, Luigi Aurisicchio, Isabella Andreini, Emanuele Marra, Laura Luberto, (unknown), (unknown), L. Monetini, Abraham Nyska	5
5	Genetic Vaccination as a Flexible Tool to Overcome the Immunological Complexity of Invasive Fungal Infections 2021 ·Frontiers in Microbiology ·Laura Luberto, Bruna Neroni, Orietta Gandini, Ersilia Fiscarelli, Giovanni Salvatori, Giuseppe Roscilli, Emanuele Marra	1
6	MITO-Luc/GFP zebrafish model to assess spatial and temporal evolution of cell proliferation in vivo 2021 ·Scientific Reports ·(unknown), Isabella Manni, (unknown), Federica Pisati, Maria Grazia Totaro, Aymone Gurtner, Emanuele Marra, (unknown), Ombretta Pozzoli, Luigi Aurisicchio, Maurizio C. Capogrossi, Gianluca Deflorian, Giulia Piaggio	3
7	A new humanized antibody is effective against pathogenic fungi in vitro 2021 ·Scientific Reports ·(unknown), (unknown), Pierpaolo Bruscolini, S. Pérez-Gaviro, Emanuele Marra, Giuseppe Roscilli, Marzia Bianchi, Alessandra Fraternale, Giuditta Fiorella Schiavano, Barbara Canonico, Mauro Magnani	22
8	SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines 2020 ·Journal of Translational Medicine ·Giovanni Salvatori, Laura Luberto, Mariano Maffei, Luigi Aurisicchio, Giuseppe Roscilli, Fabio Palombo, Emanuele Marra	132
9	Are Genetic Vaccines the Right Weapon against COVID-19? 2020 ·Molecular Therapy ·Antonella Conforti, Emanuele Marra, Giuseppe Roscilli, Fabio Palombo, Gennaro Ciliberto, Luigi Aurisicchio	11
10	The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses? 2019 ·Frontiers in Pharmacology ·(unknown), (unknown), Luigi Aurisicchio, Mauro Magnani, Emanuele Marra	46
11	Superior Immunologic and Therapeutic Efficacy of a Xenogeneic Genetic Cancer Vaccine Targeting Carcinoembryonic Human Antigen 2015 ·Human Gene Therapy ·Luigi Aurisicchio, Giuseppe Roscilli, Emanuele Marra, Laura Luberto, Rita Mancini, Nicola La Monica, Gennaro Ciliberto	6
12	Carnitines slow down tumor development of colon cancer in the DMH‐chemical carcinogenesis mouse model 2013 ·Journal of Cellular Biochemistry ·Giuseppe Roscilli, Emanuele Marra, Federica Mori, Arianna Di Napoli, Rita Mancini, Ottaviano Serlupi‐Crescenzi, Ashraf Virmani, Luigi Aurisicchio, Gennaro Ciliberto	19
13	Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies 2013 ·Journal of Translational Medicine ·Luigi Fattore, Emanuele Marra, Maria Elena Pisanu, Alessia Noto, Claudia De Vitis, Francesca Belleudi, Luigi Aurisicchio, Rita Mancini, Maria Rosaria Torrisi, Paolo A. Ascierto, Gennaro Ciliberto	56
14	Safety and Efficacy of a Genetic Vaccine Targeting Telomerase Plus Chemotherapy for the Therapy of Canine B-Cell Lymphoma 2013 ·Human Gene Therapy ·Alessandra Gavazza, George Lubas, Arthur Fridman, Daniela Peruzzi, Joseph A. Impellizeri, Laura Luberto, Emanuele Marra, Giuseppe Roscilli, Gennaro Ciliberto, Luigi Aurisicchio	36
15	Monoclonal antibody-induced ErbB3 receptor internalization and degradation inhibits growth and migration of human melanoma cells 2012 ·Cell Cycle ·Francesca Belleudi, Emanuele Marra, Francesca Mazzetta, Luigi Fattore, Maria Rosaria Giovagnoli, Rita Mancini, Luigi Aurisicchio, Maria Rosaria Torrisi, Gennaro Ciliberto	28
16	Kinesin spindle protein SiRNA slows tumor progression 2012 ·Journal of Cellular Physiology ·Emanuele Marra, Fabio Palombo, Gennaro Ciliberto, Luigi Aurisicchio	23
17	Novel anti‐ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors 2011 ·Journal of Cellular Physiology ·Luigi Aurisicchio, Emanuele Marra, Laura Luberto, (unknown), Claudia De Vitis, Alessia Noto, (unknown), Giuseppe Roscilli, Giuseppe Mesiti, Rita Mancini, Maurizio Alimandi, Gennaro Ciliberto	31
18	Intratumor RNA interference of cell cycle genes slows down tumor progression 2011 ·Gene Therapy ·Sridhar Dharmapuri, Daniela Peruzzi, Emanuele Marra, Fabio Palombo, Andrew J. Bett, (unknown), Yong Mao, Gennaro Ciliberto, Nicola La Monica, Carolyn A. Buser, Carlo Toniatti, Luigi Aurisicchio	10
19	Growth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways 2010 ·BMC Cancer ·Emanuele Marra, Paolo Uva, (unknown), Valeria Simonelli, Eugenia Dogliotti, Emanuele de Rinaldis, Armin Lahm, Nicola La Monica, Alfredo Nicosia, Gennaro Ciliberto, Fabio Palombo	32
20	Development of Humanized Mice for the Study of Hepatitis C Virus Infection 2006 ·Transplantation Proceedings ·Paolo Turrini, (unknown), (unknown), (unknown), (unknown), Antonio Di Marco, Emanuele Marra, Giacomo Paonessa, (unknown), R. Laufer, Giovanni Migliaccio, José M. Padrón	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact